Evidence map›Paper›PMID 19503634›Full record

ArticleBlood transfusion = Trasfusione del sangue2009

A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting.

Guillermo J Ruiz-Delgado, Karla I Gutiérrez-Riveroll, César H Gutiérrez-Aguirre, David Gómez-Almaguer, Renee Eyzaguirre-Zapata, Manuel Priesca-Marin, Martha L González-Carrillo, Guillermo J Ruiz-Argüelles

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Guillermo J Ruiz-DelgadoCentro de Hematología y Medicina Interna de Puebla, 8B Sur 3710, 72530 Puebla, PUE - Mexico. gruiz2@clinicaruiz.com
Karla I Gutiérrez-Riveroll
César H Gutiérrez-Aguirre
David Gómez-Almaguer
Renee Eyzaguirre-Zapata
Manuel Priesca-Marin
Martha L González-Carrillo
Guillermo J Ruiz-Argüelles
Clínica Ruiz · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 1999, in Mexico we have been using a regimen to conduct allografts that involves non-myeloablative conditioning and peripheral blood stem cells (PBSC) and have introduced some changes with the main goal of decreasing the cost of the procedure. MATERIALS AND

methodsWe analysed the salient apheresis features of a group of 175 allogeneic peripheral blood stem cell transplants conducted in two institutions in a 7-year period. The grafts were conducted using the "Mexican" non-myelo ablative conditioning regimen employing oral busulphan, i.v. cyclophosphamide and i.v. fludarabine. In all instances, the apheresis machine employed was the Baxter CS3000 Plus and donors were mobilised with filgrastim. The apheresis procedures were performed on days 0, +1 and +2, the end-point of collection being 5,000 mL of blood/m2 in each procedure. Three apheresis sessions were planned but the number was adjusted according to the cell yield.

resultsThe final number of allografted CD34 cells ranged between 0.5 and 25.4 x 10(6)/Kg of the recipient's body weight (median, 5.2 x 10(6)/Kg). One to three apheresis procedures were needed to obtain a product containing more than 0.5 x 10(6) CD34 cells/Kg of the recipient, the median being two procedures; in 72 cases (41%) a single apheresis procedure was sufficient to obtain the target number of CD34 cells. The volumes of apheresis ranged between 50 and 600 mL (median, 400 mL).

conclusionsSince the median cost of each apheresis procedure is 900 USD, the fact that two apheresis procedures was spared in 72 cases and one apheresis was spared in another 65 cases, led to a total saving of approximately 188,100 USD. It can be concluded that, in many cases, allogeneic transplants can be completed with a single apheresis session and that there are considerable financial benefits from this practice.

Indexed as

Blood DonorsCatheter AblationAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalBusulfanCost-Benefit AnalysisCyclophosphamideFilgrastimGranulocyte Colony-Stimulating FactorHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMexicoPrecursor Cell Lymphoblastic Leukemia-LymphomaBusulfanCyclophosphamideFilgrastimfludarabineGranulocyte Colony-Stimulating FactorRecombinant ProteinsVidarabineallograftsapheresiscosts savingtransplantation

Identifiers

PMID19503634
PMCPMC2689067
OpenAlexW1483206867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.